{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T19:57:58Z","timestamp":1776369478953,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T00:00:00Z","timestamp":1418083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s11096-014-0046-3","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T14:58:10Z","timestamp":1418050690000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adverse drug reaction-related hospitalisations among patients with heart failure at two hospitals in the United Arab Emirates"],"prefix":"10.1007","volume":"37","author":[{"given":"Narjes","family":"Saheb Sharif-Askari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Azhar","family":"Syed Sulaiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Saheb Sharif-Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Al Sayed","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,9]]},"reference":[{"issue":"7456","key":"46_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329(7456):15\u20139.","journal-title":"BMJ"},{"issue":"15","key":"46_CR2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279(15):1200\u20135.","journal-title":"JAMA"},{"issue":"4","key":"46_CR3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2007.03064.x","volume":"65","author":"K Wester","year":"2008","unstructured":"Wester K, J\u00f6nsson AK, Spigset O, Druid H, H\u00e4gg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2008;65(4):573\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"7\u20138","key":"46_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/106002809302700702","volume":"27","author":"TR Einarson","year":"1993","unstructured":"Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993;27(7\u20138):832\u201340.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"46_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/clpt.2009.89","volume":"86","author":"C Catananti","year":"2009","unstructured":"Catananti C, Liperoti R, Settanni S, Lattanzio F, Bernabei R, Fialova D, et al. Heart failure and adverse drug reactions among hospitalized older adults. Clin Pharmacol Ther. 2009;86(3):307\u201310.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"46_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40262-012-0029-2","volume":"52","author":"R Ogawa","year":"2013","unstructured":"Ogawa R, Stachnik JM, Echizen H. Clinical pharmacokinetics of drugs in patients with heart failure. Clin Pharmacokinet. 2013;52(3):169\u201385.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"46_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","volume":"102","author":"HL Hillege","year":"2000","unstructured":"Hillege HL, Girbes ARJ, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102(2):203\u201310.","journal-title":"Circulation"},{"issue":"2","key":"46_CR8","first-page":"74","volume":"28","author":"PA Hines","year":"2010","unstructured":"Hines PA, Yu K, Randall M. Preventing heart failure readmissions: is your organization prepared. Nurs Econ. 2010;28(2):74\u201386.","journal-title":"Nurs Econ"},{"issue":"9237","key":"46_CR9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139.","journal-title":"Lancet"},{"key":"46_CR10","first-page":"18","volume-title":"Textbook of adverse drug reactions","author":"MD Rawlins","year":"1991","unstructured":"Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press; 1991. p. 18\u201345."},{"key":"46_CR11","first-page":"253","volume-title":"Nomenclature and criteria for diagnosis of diseases of the heart and great vessels","author":"Criteria Committee of the New York Heart Association","year":"1994","unstructured":"Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston: Little Brown; 1994. p. 253\u20136.","edition":"9"},{"issue":"5","key":"46_CR12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"2","key":"46_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"46_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","volume":"228","author":"J Hallas","year":"1990","unstructured":"Hallas J, Harvald B, Gram LF, Grodum E, Br\u00d8sen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83\u201390.","journal-title":"J Intern Med"},{"issue":"8","key":"46_CR15","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0","volume":"19","author":"EW Steyerberg","year":"2000","unstructured":"Steyerberg EW, Eijkemans MJC, Harrell FE, Habbema JDF. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19(8):1059\u201379.","journal-title":"Stat Med"},{"issue":"6","key":"46_CR16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710\u20138.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"46_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2796.1990.tb00249.x","volume":"228","author":"J Hallas","year":"1990","unstructured":"Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N. Drug related admissions to a cardiology department; frequency and avoidability. J Intern Med. 1990;228(4):379\u201384.","journal-title":"J Intern Med"},{"issue":"1","key":"46_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01061423","volume":"34","author":"F Davidsen","year":"1988","unstructured":"Davidsen F, Haghfelt T, Gram LF, Brosen K. Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol. 1988;34(1):83\u20136.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"46_CR19","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50(12):1962\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"46_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00002018-200629020-00006","volume":"29","author":"CS Hooft van Der","year":"2006","unstructured":"van Der Hooft CS, Sturkenboom MCJM, van Grootheest K, Kingma HJ, Stricker BHC. Adverse drug reaction-related hospitalisations. Drug Saf. 2006;29(2):161\u20138.","journal-title":"Drug Saf"},{"issue":"1","key":"46_CR21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1345\/aph.1C126","volume":"37","author":"H Peyriere","year":"2003","unstructured":"Peyriere H, Cassan S, Floutard E, Riviere S, Blayac J-P, Hillaire-Buys D, et al. Adverse drug events associated with hospital admission. Ann Pharmacother. 2003;37(1):5\u201311.","journal-title":"Ann Pharmacother"},{"issue":"13","key":"46_CR22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","volume":"170","author":"G Onder","year":"2010","unstructured":"Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, Somers A, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65\u00a0years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142\u20138.","journal-title":"Arch Intern Med"},{"issue":"4","key":"46_CR23","doi-asserted-by":"crossref","first-page":"95991","DOI":"10.1371\/journal.pone.0095991","volume":"9","author":"FS Sharif-Askari","year":"2014","unstructured":"Sharif-Askari FS, Sulaiman SAS, Sharif-Askari NS, Hussain AAS. Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease. PLoS One. 2014;9(4):95991.","journal-title":"PLoS One"},{"issue":"10","key":"46_CR24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","volume":"30","author":"K Johnell","year":"2007","unstructured":"Johnell K, Klarin I. The relationship between number of drugs and potential drug\u2013drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register. Drug Saf. 2007;30(10):911\u20138.","journal-title":"Drug Saf"},{"issue":"7115","key":"46_CR25","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","volume":"315","author":"PA Rochon","year":"1997","unstructured":"Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315(7115):1096\u20139.","journal-title":"BMJ"},{"issue":"3","key":"46_CR26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2165\/00002018-199717030-00003","volume":"17","author":"J Feenstra","year":"1997","unstructured":"Feenstra J, Grobbee DE, Mosterd A, Stricker BH. Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure. Drug Saf. 1997;17(3):166\u201380.","journal-title":"Drug Saf"},{"issue":"7504","key":"46_CR27","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/bmj.330.7504.1370","volume":"330","author":"H Marie","year":"2005","unstructured":"Marie H, Hugues R, Louise P. Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study. BMJ. 2005;330(7504):1370.","journal-title":"BMJ"},{"issue":"3","key":"46_CR28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.162.3.265","volume":"162","author":"J Feenstra","year":"2002","unstructured":"Feenstra J, Heerdink ER, Grobbee DE, Stricker B. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the rotterdam study. Arch Intern Med. 2002;162(3):265\u201370.","journal-title":"Arch Intern Med"},{"issue":"2","key":"46_CR29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archinternmed.2008.525","volume":"169","author":"GH Gislason","year":"2009","unstructured":"Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosbol EL, et al. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med. 2009;169(2):141\u20139.","journal-title":"Arch Intern Med"},{"issue":"6","key":"46_CR30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","volume":"160","author":"J Page","year":"2000","unstructured":"Page J, Henry D. Consumption of nsaids and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med. 2000;160(6):777\u201384.","journal-title":"Arch Intern Med"},{"issue":"16","key":"46_CR31","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240\u2013327.","journal-title":"Circulation"},{"issue":"4","key":"46_CR32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.104.475673","volume":"115","author":"JD Brown","year":"2007","unstructured":"Brown JD, Plutzky J. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation. 2007;115(4):518\u201333.","journal-title":"Circulation"},{"issue":"8","key":"46_CR33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm1278","volume":"11","author":"Y Guan","year":"2005","unstructured":"Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, et al. Thiazolidinediones expand body fluid volume through PPAR\u03b3 stimulation of ENaC-mediated renal salt absorption. Nat Med. 2005;11(8):861\u20136.","journal-title":"Nat Med"},{"key":"46_CR34","doi-asserted-by":"crossref","first-page":"943614","DOI":"10.1155\/2008\/943614","volume":"2008","author":"T Yang","year":"2008","unstructured":"Yang T, Soodvilai S. Renal and vascular mechanisms of thiazolidinedione-induced fluid retention. PPAR Res. 2008;2008:943614.","journal-title":"PPAR Res"},{"issue":"22","key":"46_CR35","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.298.22.2634","volume":"298","author":"LL Lipscombe","year":"2007","unstructured":"Lipscombe LL, Gomes T, L\u00e9vesque LE, Hux JE, Juurlink DN, Alter DA. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA. 2007;298(22):2634\u201343.","journal-title":"JAMA"},{"issue":"11","key":"46_CR36","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2337\/diacare.26.11.2983","volume":"26","author":"TE Delea","year":"2003","unstructured":"Delea TE, Edelsberg JS, Hagiwara M, Oster G, Phillips LS. Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes a retrospective cohort study. Diabetes Care. 2003;26(11):2983\u20139.","journal-title":"Diabetes Care"},{"issue":"16","key":"46_CR37","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jacc.2006.10.077","volume":"49","author":"HJ Dargie","year":"2007","unstructured":"Dargie HJ, Hildebrandt PR, Riegger GAJ, McMurray JJV, McMorn SO, Roberts JN, et al. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association functional class I or II heart failure. J Am Coll Cardiol. 2007;49(16):1696\u2013704.","journal-title":"J Am Coll Cardiol"},{"issue":"9593","key":"46_CR38","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","volume":"370","author":"RM Lago","year":"2007","unstructured":"Lago RM, Singh PP, Nesto RW. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet. 2007;370(9593):1129\u201336.","journal-title":"Lancet"},{"issue":"9681","key":"46_CR39","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","volume":"373","author":"PD Home","year":"2009","unstructured":"Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet. 2009;373(9681):2125\u201335.","journal-title":"Lancet"},{"issue":"7","key":"46_CR40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurheartj\/ehp604","volume":"31","author":"M Komajda","year":"2010","unstructured":"Komajda M, McMurray JJV, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock SJ, et al. Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J. 2010;31(7):824\u201331.","journal-title":"Eur Heart J"},{"issue":"23","key":"46_CR41","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","volume":"108","author":"RW Nesto","year":"2003","unstructured":"Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation. 2003;108(23):2941\u20138.","journal-title":"Circulation"},{"issue":"7","key":"46_CR42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/archinte.168.7.687","volume":"168","author":"SL Koshman","year":"2008","unstructured":"Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7):687.","journal-title":"Arch Intern Med"},{"issue":"15","key":"46_CR43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.280.15.1317","volume":"280","author":"RA Raschke","year":"1998","unstructured":"Raschke RA, Gollihare B, Wunderlich TA, Guidry JR, Leibowitz AI, Peirce JC, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA. 1998;280(15):1317\u201320.","journal-title":"JAMA"},{"issue":"3","key":"46_CR44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2036.2004.01854.x","volume":"19","author":"H Dormann","year":"2004","unstructured":"Dormann H, Criegee-Rieck M, Neubert A, Egger T, Levy M, Hahn EG, et al. Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterology. Aliment Pharmacol Ther. 2004;19(3):303\u20139.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-014-0046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-014-0046-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-014-0046-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:42:28Z","timestamp":1747179748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-014-0046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1007\/s11096-014-0046-3","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,9]]}}}